Company · CIK 0001492422
Apellis Pharmaceuticals, Inc.
APLSSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KAPLSCurrent report0001193125-26-222923 · 505.6 KBSEC(opens sec.gov)
- 10-QAPLSQuarterly update0001492422-26-000108 · 8.7 MBSEC(opens sec.gov)
- 8-KAPLSCurrent report0001193125-26-202504 · 136.3 KBSEC(opens sec.gov)
- 10-K/AAPLSApellis Pharmaceuticals, Inc.0001492422-26-000103 · 2.7 MBSEC(opens sec.gov)
- 8-KAPLSCurrent report0001193125-26-134916 · 1.2 MBSEC(opens sec.gov)
- 8-KAPLSCurrent report0001193125-26-084156 · 137.2 KBSEC(opens sec.gov)
- 10-KAPLSAnnual report0001193125-26-065179 · 19.7 MBSEC(opens sec.gov)
- 8-KAPLSCurrent report0001193125-26-010540 · 208.7 KBSEC(opens sec.gov)
- 10-QAPLSQuarterly update0001193125-25-257374 · 11.3 MBSEC(opens sec.gov)
- 10-QAPLSQuarterly update0000950170-25-100545 · 10.1 MBSEC(opens sec.gov)
Insiders
- AJU IB Investment Co., Ltd.10% Owner
- Axon StevenChief Business Officer
- Baumal CarolineChief Medical Officer
- BIOGEN INC.See footnotes
- Boucher KelleyChief People Officer
- Brown Victoria L.Program Team Lead
- Celona LuciaSee Remarks
- Chan GeraldDirector
- Chen BihuaDirector, 10% Owner
- Chopas James GeorgeVP/Chief Accounting Officer
Tickers
Addresses
business
100 FIFTH AVENUE
WALTHAM, MA, 02451
mailing
100 FIFTH AVENUE
WALTHAM, MA, 02451
Same industry